Literature DB >> 17371817

Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.

A Stucki1, M Cottagnoud, V Winkelmann, T Schaffner, P Cottagnoud.   

Abstract

Daptomycin monotherapy was superior to ceftriaxone monotherapy and was highly efficacious in experimental pneumococcal meningitis, sterilizing the cerebrospinal fluid (CSF) of three of three rabbits after 4 to 6 h. With daptomycin therapy only a negligible release of [(3)H]choline as marker of cell wall lysis was detectable in the CSF, peaking around 250 cpm/min after 4 h, compared to a peak of around 2,400 cpm/min after 4 to 6 h for the ceftriaxone-treated rabbits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371817      PMCID: PMC1891375          DOI: 10.1128/AAC.01000-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Uwe Koedel; William Michael Scheld; Hans-Walter Pfister
Journal:  Lancet Infect Dis       Date:  2002-12       Impact factor: 25.071

2.  Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

Authors:  Peter Gerber; Armin Stucki; Fernando Acosta; Marianne Cottagnoud; Philippe Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2006-02-03       Impact factor: 5.790

3.  Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Authors:  A Schuchat; K Robinson; J D Wenger; L H Harrison; M Farley; A L Reingold; L Lefkowitz; B A Perkins
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

4.  Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.

Authors:  Philippe Cottagnoud; Marc Pfister; Fernando Acosta; Marianne Cottagnoud; Lukas Flatz; Felix Kühn; Hans-Peter Müller; Armin Stucki
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

5.  The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.

Authors:  E Tuomanen; A Tomasz; B Hengstler; O Zak
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  Production and release of peptidoglycan and wall teichoic acid polymers in pneumococci treated with beta-lactam antibiotics.

Authors:  H Fischer; A Tomasz
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

7.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Adverse outcomes of bacterial meningitis in school-age survivors.

Authors:  K Grimwood; V A Anderson; L Bond; C Catroppa; R L Hore; E H Keir; T Nolan; D M Roberton
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

10.  Rifampin for therapy of experimental pneumococcal meningitis in rabbits.

Authors:  R Nau; K Kaye; M Sachdeva; E R Sande; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  11 in total

1.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Treatment of Drug-resistant Pneumococcal Meningitis.

Authors:  Nida Hameed; Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

4.  Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis.

Authors:  Lukas Muri; Michael Perny; Jonas Zemp; Denis Grandgirard; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 5.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Kevin Oberson; Angela Bühlmann; Rahel Gäumann; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

7.  Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.

Authors:  U Egermann; Z Stanga; A Ramin; F Acosta; A Stucki; P Gerber; M Cottagnoud; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

8.  Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis.

Authors:  Tatiana Barichello; João Carlos Nepomuceno Gonçalves; Jaqueline S Generoso; Graziele L Milioli; Cintia Silvestre; Caroline S Costa; Jaqueline da Rosa Coelho; Clarissa M Comim; João Quevedo
Journal:  BMC Neurosci       Date:  2013-04-02       Impact factor: 3.288

9.  Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.

Authors:  Lukas Muri; Denis Grandgirard; Michelle Buri; Michael Perny; Stephen L Leib
Journal:  J Neuroinflammation       Date:  2018-08-21       Impact factor: 8.322

10.  Daptomycin in experimental murine pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Mark S Rouse; Cheol-In Kang; Diederik van de Beek; James M Steckelberg; Robin Patel
Journal:  BMC Infect Dis       Date:  2009-04-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.